Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Drug Alcohol Rev ; 2024 Jun 17.
Artigo em Inglês | MEDLINE | ID: mdl-38884374

RESUMO

INTRODUCTION: Opioid agonist treatment (OAT) is an effective treatment for opioid dependence syndrome in adults. However, studies on effectiveness of OAT in adolescents are limited; existing studies show varying retention rates. The present study aimed to assess OAT retention rates in adolescent patients with opioid dependence syndrome registered in a community drug treatment clinic in Delhi, India, and to analyse factors associated with retention at 1 year. METHODS: Retrospective cohort study. All adolescents (n = 130) aged 10-19 years, started on OAT from January 2020 to July 2022 were included. Baseline and follow-up data was extracted from online record system maintained at the clinic. OAT retention rates at different timepoints were assessed. Multivariable logistic regression was used to discern factors associated with one-year retention. RESULTS: The participants' mean age was 16.9 (SD 1.4) years. Mean age of starting opioids was 14.9 (SD 2.2) years; 29.5% (n = 38) injected opioids. The 6-, 12-, 18- and 24-month retention rate on OAT was 64.4%, 45.6%, 38.7% and 29% respectively. The retention rates with buprenorphine and methadone were comparable. Multivariate logistic regression showed retention for less than 12 months to be significantly associated with younger age of starting heroin, involvement in illegal activities, absenteeism from school and substance use in family. DISCUSSION AND CONCLUSIONS: The 12-month retention rates on OAT in adolescents is comparable to retention rates in adults. Various factors associated with early age of onset of opioid use are also associated with lower retention rates on OAT.

2.
Asian J Psychiatr ; 95: 103979, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38442535

RESUMO

BACKGROUND: Methadone take-home doses for opioid dependence treatment are strictly regulated due to diversion and overdose concerns, so patients must visit the clinic daily for dispensing. This was also done in India until the COVID-19 pandemic, when lockdown restriction compelled take- home dispensing of methadone. This study examined experience of patients who received take- home methadone during COVID-19 pandemic in India. METHODS: Observational, cross-sectional design. We contacted all consenting methadone centres in India during the lockdown and selected those that provided take-home doses for the study. Patients who received daily methadone before the lockdown and take-home doses after were interviewed using a study-specific questionnaire. RESULTS: The study had 210 participants. Take-home methadone was dispensed for 2.5 days on average in each dispensing. When taking methadone at home, 3.3% split their dose 25% took less than the prescribed dose to save it for a rainy days, and 3.3% reported an overdose episode. Adherence improved in 58.6% participants after take-home methadone. Participants perceived many benefits from take-home methadone such as reduced hospital visits and travel time to collect methadone, improvement in work, and financial savings. About 54.3% participants reported storing their take-home doses safely, and 1.9% reported that their family consumed methadone by mistake. CONCLUSIONS: Take-home methadone was found to be beneficial to most participants in terms of time saved and improved productivity. Preconceived concerns of providing take-home methadone in terms of its overdose, diversion, or accidental ingestion by others are not commonly seen when individuals are provided take-home doses of methadone.


Assuntos
COVID-19 , Metadona , Tratamento de Substituição de Opiáceos , Transtornos Relacionados ao Uso de Opioides , Humanos , Metadona/administração & dosagem , Metadona/uso terapêutico , Índia , Tratamento de Substituição de Opiáceos/métodos , Masculino , Adulto , Feminino , Estudos Transversais , Transtornos Relacionados ao Uso de Opioides/tratamento farmacológico , Pessoa de Meia-Idade , Adesão à Medicação , Analgésicos Opioides/administração & dosagem
3.
J Family Med Prim Care ; 11(6): 2678-2684, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-36119225

RESUMO

Background: Workplace violence (WPV) is a significant problem in both developed and developing countries among healthcare workers. The study aims to examine the perspective of resident doctors on various aspects of WPV to promote a better understanding of the complexity of the problem of WPV at a tertiary care center in India. Material and Methods: Seven focus group discussions were conducted with resident doctors from various departments, which were recruited through convenience and snowball sampling. Discussions were audio recorded and transcribed verbatim to English. Thematic analysis was done using Atlas. ti 8 to generate themes, subthemes, and codes from the discussions. Results: A total of 39 resident doctors with a mean age of 28.0 ± 3.8 years were recruited. The themes that emerged during the analysis are as follows: types of WPV, risk factors for WPV, the impact of WPV, and mitigation strategies for WPV. Conclusion: Exposure to WPV is not uncommon in India. Factors associated from individual to policy level are involved in subjugating the episodes of violence. Findings from this study will contribute in devising mitigation strategies for the same.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...